Milner; Peter Henry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Milner; Peter Henry.The latest application filed is for "5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders".

Company Profile

0.6.8

Milner; Peter Henry - Essex GB
Milner; Peter Henry - Harlow GB
Milner; Peter Henry - Traingle Park NC
Milner; Peter Henry - Great Dunmow GB
Milner, Peter Henry - Great Dunmor GB
Milner, Peter Henry - Dunmow GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders App 20080318933 - Ahmed; Mahmood ; et al.	2008-12-25
Hydroxyethylamine derivatives for the treatment of Alzheimer's disease Grant 7,253,198 - Demont , et al. August 7, 2	2007-08-07
Hydroxyethylene compounds with Asp2 inhibitory activity Grant 7,160,905 - Faller , et al. January 9, 2	2007-01-09
Substituted piperidines as histamine h3 receptor ligands App 20060247227 - Bailey; James Matthew ; et al.	2006-11-02
Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I Grant 6,995,254 - Payne , et al. February 7, 2	2006-02-07
Hydroxyethylamine derivatives for the treatment of alzheimer's disease App 20060025459 - Demont; EmmanuelH ; et al.	2006-02-02
Benzamide derivatives, processes for their preparation, and their pharmaceutical use Grant 6,992,103 - Faller , et al. January 31, 2	2006-01-31
Methods of using Fab I and compounds modulating Fab I activity App 20050112713 - DeWolf, Walter E. JR. ; et al.	2005-05-26
Benzamide derivatives, processes for their preparation, and their pharmaceutical use App 20050085520 - Faller, Andrew ; et al.	2005-04-21
Hydroxyethylene compounds with asp2 inhibitory activity App 20050038028 - Faller, Andrew ; et al.	2005-02-17
Novel compounds App 20040209822 - Faller, Andrew ; et al.	2004-10-21
FabI Grant 6,753,172 - Payne , et al. June 22, 2	2004-06-22
2,'3-Amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors App 20030207923 - Faller, Andrew ; et al.	2003-11-06
Polynucleotides encoding staphylcoccal FAB I enoyl-ACP reductase Grant 6,432,670 - Payne , et al. August 13, 2	2002-08-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.